JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Toggle Nav

Search

Menu

Account

Technical Notes and Application Notes

Immunotherapy | Cancer Targets | Adoptive Cell Therapy | Gene & Cell Therapy | Metabolism | Cell Culture | RNA Editing | Cancer Pathways | CRISPR/Cas9 | Cell Receptor Targets | Ubiquitination | Protein Sciences | Technology | Cholesterol Pathways | SARS-CoV-2/COVID-19

Immunotherapy

OX40 Signaling and Its Implications for Immunotherapy

OX40 Signaling and Its Implications for Immunotherapy

TL1A:DR3 - A Pathway for Immunomodulation

TL1A:DR3 - A Pathway for Immunomodulation

Therapeutic Targeting of TSLP in Asthma and COPD

Therapeutic Targeting of TSLP in Asthma and COPD

A2aR & Immunotherapy

A2aR & Immunotherapy

BCMA & Cancer

BCMA & Cancer

Bispecific Antibodies

Combination Therapies for Targeting Immune Checkpoints

Combination Therapies for Targeting Immune Checkpoints

Immune Checkpoints & Drug Discovery

Immune Checkpoints & Drug Discovery

LAG3 Cotherapies

LAG3 Cotherapies

Siglecs & Immunotherapy

Siglecs & Immunotherapy

TIGIT, CD155 & CD226

TIGIT, CD155 & CD226

Cancer Targets

Cellular PARylation: From Inquiry to Insight in Drug Discovery

Cellular PARylation: From Inquiry to Insight in Drug Discovery

Setting a Trap for PARP1 and PARP2

Claudin-18: A Therapeutic Target in Oncology

Claudin-18: A Therapeutic Target in Oncology

Structure and Function of the Claudin Family

Structure and Function of the Claudin Family

CD39 & CD73: Adenosine Signaling

CD39 & CD73: Adenosine Signaling

PRMT5 & Cancer

PRMT5 Methylation

RAS Mutations & Cancer Research (Updated Nov 2023)

RAS Mutations & Cancer Research

Adoptive Cell Therapy

The Promise of NK Cell Therapeutics

CAR-T Cell Therapy

CAR-T Cell Therapy

The landscape of T cell immunotherapies

The landscape of T cell immunotherapies

Gene & Cell Therapy

AAV and Gene Therapy - Part 1

AAV and Gene Therapy

AAVs: Toolbox for Gene Therapy Research - Part 2

AAV and Gene Therapy

The Power of Lentiviruses in Cell Engineering

The Power of Lentiviruses in Cell Engineering

Research Applications for Engineered iPS Cells

Metabolism

Emerging Therapeutic Concepts for MASH

Emerging Therapeutic Concepts for MASH

Cell Culture

Cell Lysis Buffers

Cell Lysis Buffers

The Impact of Cell Culture Conditions and Media in Cellular Studies

RNA Editing

Role of ADAR1 in Biology & Disease

Role of ADAR1 in Biology & Disease

Cancer Pathways

IDO/TDO Pathway

IDO/TDO Pathway

JAK & STAT

JAK & STAT

NAMPT & Cancer

NAMPT & Cancer

Nicotinamide Adenine Dinucleotide

Nicotinamide Adenine Dinucleotide

CRISPR/Cas9

CRISPR-Based Synergistic Activation Mediator (SAM)

CRISPR-Based Synergistic Activation Mediator (SAM)

CRISPR Products & Services

CRISPR Products & Services

Cell Receptor Targets

GLP-1R & Diabetes

HVEM, LIGHT, & BTLA

HVEM, LIGHT, & BTLA

IgG Antibodies

IgG Antibodies

Transferrin Receptor pt. 1

Ubiquitination

Ubiquitination and CBL

Ubiquitination and CBL

Targeted Protein Degradation Approaches and Applications

Targeted Protein Degradation Approaches and Applications

Protein Sciences

Enzymatic Biotinylation & BirA

Enzymatic Biotinylation & BirA

Sortase-Mediated Protein Ligation

Sortase-Mediated Protein Ligation

Virus-like Particles-embeded Proteins

Virus-like Particles-embeded Proteins

Technology

Luminescence Kinase Assays Illuminate the Path to Inhibitor Discovery

Luminescence Kinase Assays Illuminate the Path to Inhibitor Discovery

TR-FRET Assays Simplify and Accelerate Drug Discovery

TR-FRET Assays Simplify and Accelerate Drug Discovery

Artificial Intelligence (AI) in Drug Discovery

Artificial Intelligence (AI) in Drug Discovery

Fluorescence Polarization Assays: Principles & Applications

Cholesterol Pathways

Cholesterol & the PCSK9 Pathway

Cholesterol & the PCSK9 Pathway

SARS-CoV-2/COVID-19

App Note: SARS-CoV-2 Spike Pseudoviruses

App Note: SARS-CoV-2 Spike Pseudoviruses

Lentiviruses for SARS-CoV-2 Research

Lentiviruses for SARS-CoV-2 Research

Proteases as Targets for SARS-CoV-2 Treatment

Proteases as Targets for SARS-CoV-2 Treatment

SARS-CoV-2 Accessory Proteins & ORF9B

SARS-CoV-2 Accessory Proteins & ORF9B

SARS-CoV-2 Antibody Detection

SARS-CoV-2 Antibody Detection

SARS-CoV-2 Coronavirus & COVID-19

SARS-CoV-2 Coronavirus & COVID-19

SARS-CoV-2 Variants: Evading the Immune System

SARS-CoV-2 Variants: Evading the Immune System

Further Resources

Related Products